Tempo is a therapeutic device company pioneering a new era in tissue regeneration, using fully-synthetic and injectable scaffolding materials that unlock the body’s own regenerative capacity by controlling tissue inflammation. Enabled by our proprietary MAP technology, our products are powered by unique physical micro-geometries - creating immune-stealth scaffolds that promote rapid, regenerative healing without the need to deliver cells or biologics. Tempo is a platform technology company led by a team of innovators, entrepreneurs, and experienced biotechnology executives. We are creating a suite of precision-engineered, mass-manufacturable clinical tools to transform therapy in tissues including skin, soft tissue, orthopedic, neural and cardiac applications. True tissue engineering has long been the unifying goal in a rapidly growing $22B market, for which Tempo holds the enabling technology. Our mission is to set the pace in the next generation of tissue therapeutics.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
TT101 - soft tissue wound regeneration matrix
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):